Liver 2018
DOI: 10.1136/gutjnl-2018-bsgabstracts.264
|View full text |Cite
|
Sign up to set email alerts
|

PTH-108 The outcome of transarterial chemoembolization for liver cancer patients in aberdeen royal infirmary

Abstract: PTH-106 Figure 3 Conclusions Plasma S100A8/A9 is significantly elevated in ACLF, correlating strongly with activation of pro-inflammatory mediators and indices of disease severity, extra-hepatic organ failure and outcome. Our in vitro data indicate that this mediator promotes inflammation and represents a novel therapeutic target in ACLF.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles